Sersen, E. A.

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 582

The fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities

Wisniewski, K. E., Segan, S. M., Miezejeski, C. M., Sersen, E. A., & Rudelli, R. D. (1991) · American Journal of Medical Genetics

Genetics and Neurodevelopmental DisordersDown syndrome and intellectual disability research

Cited by 261

Normal ageing in adults with Down's syndrome: a longitudinal study

Devenny, D. A., Silverman, W. P., Hill, A. L., Jenkins, E., Sersen, E. A., & Wisniewski, K. E. (1996) · Journal of Intellectual Disability Research

Down syndrome and intellectual disability researchDementia and Cognitive Impairment Research

Cited by 171

Increased plasma amyloid β protein 1–42 levels in Down syndrome

Mehta, P. D., Dalton, A. J., Mehta, S. P., Kim, K. S., Sersen, E. A., & Wisniewski, H. M. (1998) · Neuroscience Letters

Down syndrome and intellectual disability researchAlzheimer's disease research and treatments

Cited by 108

Sleep patterns in mental retardation: Down's syndrome

Clausen, J., Sersen, E. A., & Lidsky, A. (1977) · Electroencephalography and Clinical Neurophysiology

Sleep and Wakefulness ResearchDown syndrome and intellectual disability research

Cited by 52